yourstate.us
Home / United States / 21 CFR
21 CFR 882.4725

§ 882.4725 Radiofrequency lesion probe.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 882.4725, § 882.4725 Radiofrequency lesion probe, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/90706
Permanent ID
ys:prov:90706@1
SHA-256
e4b3240d009fe578349e30306f0f36d3df526772f93d6cfb07e55b294f522fc9

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Identification. A radiofrequency lesion probe is a device connected to a radiofrequency (RF) lesion generator to deliver the RF energy to the site within the nervous system where a lesion is desired. (b) Classification. Class II (performance standards).

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.